Department of Cardiovascular and Renal Research, Centre for Individualized Medicine in Arterial Diseases (CIMA), Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
Department of Cardiac, Thoracic and Vascular Surgery, Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Odense, Denmark.
Basic Clin Pharmacol Toxicol. 2018 Jan;122(1):74-81. doi: 10.1111/bcpt.12843. Epub 2017 Jul 30.
In human pericardial resistance arteries, effects of the endothelium-dependent vasodilator bradykinin are mediated by NO during contraction induced by K or the TxA analogue U46619 and by H O during contraction by endothelin-1 (ET-1), respectively. We tested the hypotheses that ET-1 reduces relaxing effects of NO and increases those of H O in resistance artery smooth muscle of patients with cardiovascular disease. Arterial segments, dissected from the parietal pericardium of 39 cardiothoracic surgery patients, were studied by myography during amplitude-matched contractions induced by K , the TXA analogue U46619 or ET-1. Effects of the NO donor Na-nitroprusside (SNP) and of exogenous H O were recorded in the absence and presence of inhibitors of cyclooxygenases, NO synthases and small and intermediate conductance calcium-activated K channels. During contractions induced by either of the three stimuli, the potency of SNP did not differ and was not modified by the inhibitors. In vessels contracted with ET-1, the potency of H O was on average and in terms of interindividual variability considerably larger than in K -contracted vessels. Both differences were not statistically significant in the presence of inhibitors of mechanisms of endothelium-dependent vasodilatation. In resistance arteries from patients with cardiovascular disease, ET-1 does not selectively modify smooth muscle relaxing responses to NO or H O . Furthermore, the candidate endothelium-derived relaxing factor H O also acts as an endothelium-dependent vasodilator.
在人类的心包膜阻力动脉中,内皮依赖性血管扩张剂缓激肽的作用是通过 NO 介导的,在 K 或 TxA 类似物 U46619 引起的收缩期间,以及通过 H2O 在由内皮素-1 (ET-1) 引起的收缩期间。我们测试了以下假设:ET-1 降低了 NO 的舒张作用,并增加了心血管疾病患者阻力血管平滑肌中 H2O 的作用。通过肌动描记术研究了从 39 例心胸外科手术患者的心包壁上解剖的动脉段,在 K、TXA 类似物 U46619 或 ET-1 诱导的幅度匹配收缩期间进行研究。在不存在和存在环氧化酶、NO 合酶和小和中等电导钙激活钾通道抑制剂的情况下,记录了 NO 供体 Na-硝普钠 (SNP) 和外源性 H2O 的作用。在这三种刺激物引起的收缩期间,SNP 的效力没有差异,并且不受抑制剂的影响。在用 ET-1 收缩的血管中,H2O 的效力平均而言,并且在个体间变异性方面,明显大于 K 收缩的血管。在存在内皮依赖性血管舒张机制的抑制剂的情况下,这两种差异均无统计学意义。在心血管疾病患者的阻力血管中,ET-1 不会选择性地改变平滑肌对 NO 或 H2O 的舒张反应。此外,候选内皮源性舒张因子 H2O 也作为内皮依赖性血管扩张剂起作用。